Harvard Pulmonary and Critical Care Medicine 2024

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2024 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

• Sepsis
• ARDS
• Sarcoidosis
• IPF
• Bronchiectasis
• Cystic fibrosis
• Lung nodules
• Lung cancer
• GERD
• Pleural disease
• Pneumonia
• Tuberculosis
• Thromboembolism
• Chronic cough
• COPD

• Asthma
• Occupational and environmental lung disease
• Interstitial lung disease
• Lung transplantation
• Neurologic issues in the ICU
• Sleep-disordered breathing
• Post-acute sequelae of COVID-19
• Surgical emergencies
• Atypical mycobacterial disease
• Pulmonary hypertension
• Cardiopulmonary disorders
• Complications from cardiac arrest
• Hypersensitivity pneumonitis
• Acute respiratory failure

REASONS TO ATTEND IN 2024

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

• The most current guidelines for treating sepsis
• Evidence-based treatment of ARDS
• State of the art in interventional pulmonology
• High-flow oxygen therapy for respiratory failure
• Updates on biologics in asthma and other lung disease
  • New concepts in the use of vasopressors in septic shock
  • New drugs and combinations in pulmonary hypertension
  • New evidence on sedation, analgesia, and early mobility
  • Point-of-care pulmonary ultrasound in the intensive care unit
  • Lung microbiome: emerging implications for lung health
  • Emerging evidence for targeted temperature management
  • Evaluating occupational and environmental lung disease
  • Steroid-sparing agents for interstitial lung disease
  • Pulmonary embolus: the latest treatment strategies
  • State-of-the-art management of the critically ill patient
  • Guidance to conduct end-of-life discussions
  • Updates in pulmonary pathology
  • New treatment options in cystic fibrosis
  • Handling neurologic and surgical emergencies in the medical ICU
  • New approaches that improve outcomes for patients with unexplained chronic cough
• Syllabus